article thumbnail

Who’s Liable for Bad Medical Advice in the Age of ChatGPT?

Bill of Health

For these individuals, the possibility of medical malpractice claims and Health Insurance Portability and Accountability Act (HIPAA) violations looms large. HIPAA Violations Entirely separate from concerns about malpractice, health care providers also need to be aware of the privacy implications of using ChatGPT.

article thumbnail

What Malpractice Liabilities Do Healthcare AI Users Face?

Healthcare IT Today

With many providers adopting AI technology, it’s likely that some of them will face medical malpractice suits blaming the AI for patient harm. While it’s still unclear how to tackle this problem, it’s clear that healthcare organizations will have to address it soon. According to Saurabh Jah, who wrote a piece on this subject for […].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Key Considerations for Patient-Reported Outcome Measures

Bill of Health

PROM responses can be used for purposes of clinical care, research, quality improvement, Food and Drug Administration (FDA) approval of drugs and devices, and even insurance reimbursement. In the legal realm, both privacy and medical malpractice vulnerabilities are of concern. Medical malpractice could occur for two reasons.

article thumbnail

EU and US Regulatory Challenges Facing AI Health Care Innovator Firms

Bill of Health

In a similar vein, FDA only considers medical AI that falls in one of its existing regulatory categories (most often medical device), and even then by way of Congressional action and FDA’s own interpretation of its authority, and its discretion only regulates a subset of medical AI. A different example has to do with how the U.S.

FDA 282
article thumbnail

Unpacking Averages: Understanding the Potential for Bias in a Sepsis Prediction Algorithm, a Case Study

Health Law Advisor

The FDA has been pursuing a solution. [15] 23] According to FDA guidance, the agency regulates clinical decision support software whose output (a) suggests “that a specific patient ‘may exhibit signs’ of a disease or condition” or (b) “identifies a risk probability or risk score for a specific or condition.”

FDA 98
article thumbnail

Health Provider News – May 13, 2022

Hall Render

FDA limits J&J COVID-19 vaccine due to rare blood clot risk. Judge awards $5 million to NH woman in medical malpractice case. 340B hospitals amplify loss projections as more drugmakers unveil restrictions. HHS appeal of No Surprises Act on hold. HHS awards $16.3M toward telehealth for family planning. NEW HAMPSHIRE. Some of N.H.’s

article thumbnail

Health Provider News

Hall Render

Alexius Devils Lake Hospital renovations Closing the Medicaid Gap Is Just the First Step, as Nursing Homes Fight for Predictable Reimbursement Sanford nursing director back home after an opportunity to help a hospital in Costa Rica What do malpractice payments look like in North Dakota? OHIO Buckeye Career Center receives $2.9M